Entresto
Payments companies reported to CMS as associated with Entresto. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Entresto, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Entresto
These are the largest totals companies reported as associated with Entresto. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Scott Solomon | Boston, MA | Cardiovascular Disease | $14,051.93 |
| Peter Kowey | Wynnewood, PA | Cardiovascular Disease | $11,935.27 |
| Daniel Rader | Philadelphia, PA | Internal Medicine | $11,834.43 |
| Kavita Sharma | Baltimore, MD | Advanced Heart Failure and Transplant Cardiology | $10,456.00 |
| Anthony Peters | Winston Salem, NC | Cardiovascular Disease | $8,804.60 |
| James Januzzi | Boston, MA | Cardiovascular Disease | $7,950.00 |
| Safia Chatur | Boston, MA | Cardiovascular Disease | $7,090.50 |
| Robert Mentz | Durham, NC | Cardiovascular Disease | $6,064.04 |
| Munir Janmohamed | Sacramento, CA | Advanced Heart Failure and Transplant Cardiology | $5,836.35 |
| Armando Collazo Leandry | West Palm Beach, FL | Family Medicine | $3,168.00 |
Prescribed Entresto?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.